by Nova Advertising | Oct 10, 2022 | Blog
Low Dose Naltrexone (LDN) is a non-selective antagonist of opioid receptors. Naltrexone is a unique compound, and at low doses has been shown to provide therapeutic potential in a variety of clinical settings. It is a non-controlled, safe, well-tolerated option...